Alzheimer’s

Shares of clinical-stage pharmaceutical company vTv Therapeutics Inc. (NASDAQ: VTVT) surged 50 percent Wednesday morning. What Happened The company is engaged in the research and development of treatments for Alzheimer’s disease and diabetes. This week, it announced the delivery of an...

A biotech company making a jump from the OTC market to the Nasdaq is certainly not as difficult as finding a cure for Alzheimer’s Disease. However, OTC investors are well aware that up-listings are a rare phenomenon. Neurotrope Inc (NASDAQ: NTRP) investors are hoping that the company’s...

A number of Alzheimer drug trials have fallen through in the last few months, and on Tuesday, Merck & co., Inc. (NYSE: MRK) added its verubecestat to the list of inefficacious treatments. The series of failed tests have inspired questions about the amyloid hypothesis on which recent treatments...

While factors like state tax revenue and government control are all important in the national debt on whether or not to legalize marijuana, the question at the core of the issue is whether or not the drug is good for the public's health. Conflicting information has given both sides of the...

While the long-term effects of smoking marijuana have yet to be thoroughly examined, studies across the U.S. are cropping up claiming that the drug has soothing effects for those suffering from terminal diseases. With that in mind, many are calling on the federal government to change its...

Eli Lilly & Co. (NYSE: LLY) planned to go back to the drawing board with its new experimental Alzheimer’s drug, according Bloomberg. The drug, solanezumab, which was not successful with advanced Alzheimer’s patients, will be tested in patients who show signs of early stages of the disease...